Cai Mep Proves Its Readiness for Bigger Ships

first_img Print  Close zoom Vietnam’s Cai Mep International Terminal (CMIT), owned by APM Terminals, welcomed the 14,000 TEU m/v CSCL Star on October 29, 2015, following dredging works that enabled it to receive bigger vessels.The maiden visit of the ultra large container vessel (ULCV) of 157,000 DWT, deployed in the Ocean 3 Alliance, marked the first Vietnam/Northern Europe direct service.Notably, within the last week, two feeder services have also started to call at CMIT to connect both the local Vietnamese export cargo and the international export cargo from Thailand and Cambodia, all transshipped through CMIT.“This operation fits well into the vision of CMIT to be the first container hub port for domestic and international transshipment. The transshipment operation is also supported by the Vietnamese Government, as Vietnam positions itself within the Cai Mep deep-water container port group to best serve the Europe-Vietnam Free Trade Agreement which was agreed to in September,” said Robert Hambleton, General Director, CMIT.The Vietnamese Ministry of Transport, Vinamarine and the VMS have all funded the Cai Mep channel maintenance dredging. This recent work has brought the channel depth down to 13.2 metres at low water, in time to receive the CSCL Star.“Collectively, the Ministry of Transport, Vinamarine and CMIT have created a new and distinctive advantage for the Cai Mep deep water port group, now capable of handling the 14,000 TEU ULCV; a capability previously reserved for the ASEAN hubs in Singapore and Malaysia,” Nguyen Xuan Ky, CMIT Deputy General Director, commented. My locationcenter_img 此页面无法正确加载 Google 地图。您是否拥有此网站?确定last_img read more

Read More →

Pfizer to absorb Mylan creating generic giant

NEW YORK — Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business.The Pfizer business, called Upjohn, makes Lipitor, Celebrex and Viagra. Mylan, based just outside of Pittsburgh, is best known for its EpiPen, an injector used to halt life-threatening allergic reactions.Pfizer Inc. shareholders will own 57% of the combined new company and Mylan shareholders will own 43%.The deal Monday arrives at a precarious time for big drug makers who are threatened by patent protection losses and lower-priced rivals.The new company will be incorporated in Delaware and run operations in Pittsburgh, Shanghai and Hyderabad, India.The combination is expected to close in the middle of next year.The Associated Press read more

Read More →